Eterna Therapeutics Inc
NASDAQ:ERNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
US |
|
N
|
National Environmental Recycling Co
SAU:9540
|
SA |
Balance Sheet
Balance Sheet Decomposition
Eterna Therapeutics Inc
Eterna Therapeutics Inc
Balance Sheet
Eterna Therapeutics Inc
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
3
|
7
|
6
|
9
|
10
|
3
|
4
|
4
|
1
|
3
|
5
|
7
|
3
|
6
|
3
|
3
|
3
|
1
|
17
|
11
|
8
|
2
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
11
|
8
|
2
|
|
| Cash Equivalents |
1
|
1
|
3
|
7
|
6
|
9
|
10
|
3
|
4
|
4
|
1
|
3
|
5
|
7
|
3
|
6
|
3
|
3
|
3
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
2
|
2
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
|
| Accounts Receivables |
1
|
2
|
2
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
1
|
3
|
9
|
4
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
6
|
5
|
4
|
6
|
3
|
2
|
1
|
1
|
1
|
2
|
0
|
|
| Total Current Assets |
4
|
4
|
7
|
14
|
17
|
15
|
13
|
5
|
5
|
5
|
3
|
4
|
8
|
15
|
9
|
11
|
10
|
7
|
6
|
2
|
19
|
14
|
10
|
2
|
|
| PP&E Net |
8
|
5
|
4
|
6
|
8
|
6
|
4
|
3
|
4
|
4
|
4
|
4
|
3
|
3
|
4
|
3
|
4
|
5
|
5
|
1
|
4
|
1
|
33
|
1
|
|
| PP&E Gross |
8
|
5
|
4
|
6
|
8
|
6
|
4
|
3
|
4
|
4
|
4
|
4
|
3
|
3
|
0
|
0
|
0
|
0
|
5
|
1
|
4
|
1
|
33
|
1
|
|
| Accumulated Depreciation |
24
|
18
|
21
|
23
|
25
|
27
|
29
|
20
|
20
|
21
|
19
|
18
|
18
|
19
|
0
|
0
|
0
|
0
|
9
|
9
|
0
|
0
|
1
|
0
|
|
| Intangible Assets |
1
|
1
|
5
|
5
|
3
|
2
|
1
|
1
|
3
|
2
|
2
|
3
|
2
|
2
|
1
|
1
|
1
|
2
|
2
|
1
|
6
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
3
|
4
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
2
|
2
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
5
|
4
|
0
|
|
| Other Assets |
0
|
0
|
3
|
4
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
2
|
2
|
2
|
|
| Total Assets |
13
N/A
|
11
-19%
|
21
+90%
|
29
+42%
|
30
+2%
|
27
-12%
|
21
-21%
|
12
-44%
|
14
+23%
|
13
-8%
|
12
-11%
|
13
+9%
|
15
+22%
|
22
+44%
|
16
-26%
|
17
+2%
|
17
-1%
|
15
-10%
|
14
-5%
|
4
-73%
|
32
+741%
|
22
-29%
|
49
+121%
|
5
-89%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
2
|
1
|
2
|
|
| Accrued Liabilities |
1
|
1
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
2
|
0
|
2
|
4
|
4
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
3
|
5
|
1
|
3
|
2
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
1
|
2
|
2
|
4
|
3
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
4
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
4
|
6
|
7
|
8
|
8
|
5
|
4
|
4
|
3
|
4
|
3
|
4
|
7
|
5
|
7
|
11
|
4
|
6
|
2
|
4
|
8
|
7
|
3
|
|
| Long-Term Debt |
5
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
7
|
5
|
0
|
3
|
0
|
1
|
0
|
1
|
7
|
0
|
|
| Minority Interest |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
1
|
3
|
0
|
2
|
1
|
34
|
1
|
|
| Total Liabilities |
10
N/A
|
9
-11%
|
8
-19%
|
7
-3%
|
9
+24%
|
8
-12%
|
5
-34%
|
4
-26%
|
5
+24%
|
4
-25%
|
5
+45%
|
5
-10%
|
6
+32%
|
11
+81%
|
13
+11%
|
13
+1%
|
11
-13%
|
8
-28%
|
9
+14%
|
3
-68%
|
6
+108%
|
10
+69%
|
47
+361%
|
4
-92%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
77
|
79
|
82
|
87
|
89
|
94
|
99
|
105
|
107
|
107
|
111
|
112
|
113
|
118
|
125
|
128
|
129
|
129
|
131
|
136
|
141
|
165
|
187
|
232
|
|
| Additional Paid In Capital |
81
|
81
|
95
|
109
|
110
|
112
|
113
|
113
|
116
|
116
|
117
|
119
|
121
|
128
|
129
|
132
|
135
|
137
|
137
|
137
|
166
|
177
|
189
|
233
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
1
|
0
|
0
|
0
|
2
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
1
-49%
|
13
+782%
|
22
+69%
|
21
-5%
|
19
-11%
|
16
-16%
|
8
-50%
|
9
+22%
|
9
+0%
|
6
-33%
|
8
+24%
|
9
+17%
|
11
+19%
|
4
-65%
|
4
+6%
|
6
+36%
|
7
+25%
|
5
-26%
|
1
-83%
|
26
+2 900%
|
12
-53%
|
2
-82%
|
2
-24%
|
|
| Total Liabilities & Equity |
13
N/A
|
11
-19%
|
21
+90%
|
29
+42%
|
30
+2%
|
27
-12%
|
21
-21%
|
12
-44%
|
14
+23%
|
13
-8%
|
12
-11%
|
13
+9%
|
15
+22%
|
22
+44%
|
16
-26%
|
17
+2%
|
17
-1%
|
15
-10%
|
14
-5%
|
4
-73%
|
32
+741%
|
22
-29%
|
49
+121%
|
5
-89%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|